...to Regulate Marijuana Like Alcohol (CTRMLA) submitted a collection of signatures in a formal petition to the Ohio state legislature, with the aim of legalizing recreational marijuana. The Ohio legislature...
FDA Approves Biosimilar for Humira The FDA recently approved Abrilada (adalimumab-afzb) a biosimilar for Humira® (adalimumab), indicated for the treatment of: Rheumatoid arthritis Juvenile idiopathic arthritis Psoriatic arthritis Ankylosing spondylitis Adult Crohn’s...
...explores the compounding challenge of worker health and recovery barriers, strategic priorities that point toward engagement and efficiency, and a shifting in technology investment as AI gains ground. Read the...
...and mobile solutions, Kennedy speaks to three opportunities for digital and mobile solutions to help improve the workers’ comp journey and outcomes, including: Outdated forms of communication, such as snail...
The Department of Justice (DOJ) announced that Medisca Inc. has agreed to pay $21.75 million to resolve allegations concerning the establishment of false and inflated Average Wholesale Prices (AWPs) for...
...challenges, and priorities of the workers’ comp industry. Approximately 500 respondents completed the survey, representing a wide range of stakeholders and industries, both in-person at the National Comp conference and...
...ongoing assessment of prescribing patterns and potential updates to the state’s workers’ compensation formulary. Staying closely engaged with the P&T Committee discussions gives Healthesystems early visibility into the clinical and...
...Referral efficiency Oversight and analytics For an in-depth look into these strategies and how workers’ comp programs can continue to get patients appropriate and cost-effective care in the face of...
Advocacy & Compliance Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays...
...as motor vehicle accidents. Frequency increases due to temperatures at the upper and lower end of the range are large and statistically significant throughout the sample period but were slightly...
The FDA has approved a new IV formulation of Combogesic® (acetaminophen and ibuprofen), with an expanded indication. Originally approved in tablet formulation in March of 2023, Combogesic was previously approved...
...and can last for weeks, months, or even years after COVID-19. Symptoms can persist, resolve, and re-emerge over weeks and months. Read the article in full at RxInformer magazine online....
...trends, challenges, and priorities of the workers’ comp industry. This survey was completed by more than 500 respondents representing a wide range of stakeholders, both in-person at the National Comp...
The FDA recently approved several abbreviated new drug applications (ANDAs), effectively introducing many first-time generic drugs to the market. Many of the drugs approved are utilized in workers’ comp, meaning...
